Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

Open access
Vogelmeier, C., D'Urzo, A., Pauwels†, R., Merino, J. M., Jaspal, M., Boutet, S., Naya, I., Price, D. · 2005 · European Respiratory Journal

Abstract

This 12-month dose-titration study assessed the effectiveness of budesonide/formoterol for maintenance plus relief with a control group using salmeterol/fluticasone for maintenance plus salbutamol for relief. Adolescents and adults (n = 2,143; mean forced expiratory volume in one second (FEV 1) 73% predicted; mean inhaled corticosteroid (ICS) 884 µg·day−1) were randomised to budesonide/formoterol 160/4.5 µg two inhalations b.i.d.plus additional inhalations as needed, or salmeterol/fluticasone 50/250 µg b.i.d.plus salbutamol as needed. Treatment was prescribed open label; after 4 weeks, physicians could titrate maintenance doses in accordance with normal clinical practice. Maintenance plus as-needed budesonide/formoterol prolonged the time to first severe exacerbation versus salmeterol/fluticasone (25% risk reduction). The total number of severe exacerbations was significantly reduced in the budesonide/formoterol group (255 versus 329). Both regimens provided sustained improvements in symptoms, as-needed use, quality of life and FEV 1, with differences in favour of the budesonide/formoterol group for as-needed use (0.58 versus 0.93 inhalations·day−1) and FEV 1(post-β 2-agonist values). Mean ICS dose during treatment was similar in both groups (653 µg budesonide·day−1(maintenance plus as-needed)versus 583 µg fluticasone·day−1). The simplified strategy using budesonide/formoterol for maintenance and reliever therapy is feasible, safe and at least as effective as salmeterol/fluticasone plus salbutamol.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.05.00028305

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 221

Metadata

Authors
Vogelmeier, C., D'Urzo, A., Pauwels†, R., Merino, J. M., Jaspal, M., Boutet, S., Naya, I., & Price, D.
Venue
European Respiratory Journal
Published
2005-11
Volume
26
Issue
5
Pages
819-828
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2157910210
Cited by
221
References
2
FWCI
10.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? https://app.cochat.ai/papers/10.1183/09031936.05.00028305
The paper
Vogelmeier, C., D'Urzo, A., Pauwels†, R., Merino, J. M., Jaspal, M., Boutet, S., Naya, I., & Price, D. (2005). Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? European Respiratory Journal. https://doi.org/10.1183/09031936.05.00028305

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.